On September 27, 2020, the non-public share offering of Zhejiang Aoxiang Pharmaceutical Co., Ltd., with Hai Run Law Firm as its specialized legal counsel, passed the 144th meeting of the 18th issuance review committee of China Securities Regulatory Commission in 2020. This project is led by Yan Kebing, senior partner of Hareon Tianrui, and undertaken by business partners Ma Jihui and lawyer Chen Haidong.

As the specialized legal counsel for this issuance, our lawyers provided full-process and comprehensive legal services including legal due diligence, transaction structure design, core document drafting, resolution of major difficult legal issues, and issuance of legal opinions at various stages, which provides a strong guarantee for smooth and efficient completion of the issuance.